Work

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

Year: 2008

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The Lancet

DOI: 10.1016/s0140-6736(08)61033-8

Authors: Alexander MM Eggermont, Stefan Suciu, Mario Santinami, Alessandro Testori, Wim HJ Kruit, Jeremy Marsden, Cornelis JA Punt, François Salès, Martin Gore, Rona MacKie, Zvonko Kusic, Reinhard Dummer, Axel Hauschild, Elena Musat, Alain Spatz, Ulrich Keilholz

Institutions: Erasmus MC, European Organisation for Research and Treatment of Cancer, Fondazione IRCCS Istituto Nazionale dei Tumori, European Institute of Oncology, Radboud University Medical Center, Institut Jules Bordet, Royal Marsden Hospital, University of Glasgow, Sisters of Charity Hospital, University Hospital Zurich, University Hospital Schleswig-Holstein, Institut Gustave Roussy, Charité – Universitätsmedizin Berlin

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2099289479

FWCI: 32.78

Cites: 25

Cited by: 655

Related to: 9